O
ARVN icon

OrbiMed’s Arvinas ARVN Stock Holding History

OrbiMed’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-29,400
Closed -$986K – 146
2020
Q2 		$986K Sell
29,400
-965,600
-97% -$41M 0.01% 134
2020
Q1 		$40.1M Sell
995,000
-903,800
-48% -$42.3M 0.68% 45
2019
Q4 		$78M Sell
1,898,800
-196,483
-9% -$5.75M 1.12% 33
2019
Q3 		$45.2M Sell
2,095,283
-583,527
-22% -$14.3M 0.87% 36
2019
Q2 		$58.9M Hold
2,678,810
– – 0.93% 36
2019
Q1 		$39.5M Hold
2,678,810
– – 0.62% 48
2018
Q4 		$34.4M Buy
2,678,810
+32,945
+1% +$523K 0.64% 51
2018
Q3 		$44.6M Buy
+2,645,865
New +$43.6M 0.54% 59

Other funds holding ARVN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return